Related Experiment Videos
Role of in vitro cholesterol depletion in mediating human platelet aggregation
S Grgurevich1, R Krishnan, M M White
1Vascular Biology Center of Excellence, Department of Medicine, and the Department of Molecular Sciences, University of Tennessee Health Science Center, Memphis, TN, USA.
Insights
Lowering cholesterol in platelets reduces their ability to aggregate. Cholesterol depletion impairs platelet ultrastructure and signaling, affecting aggregation and secretion.
Area of Science:
- Biochemistry
- Hematology
- Cell Biology
Background:
- Platelets play a crucial role in hemostasis and thrombosis.
- Cholesterol's influence on platelet function is not fully understood.
- Platelet aggregation is a key process in blood clot formation.
Purpose of the Study:
- To investigate the direct impact of cholesterol depletion on human platelet aggregation.
- To determine how cholesterol affects platelet ultrastructure and signaling pathways.
Main Methods:
- In vitro cholesterol depletion of human platelets using methyl-beta-cyclodextrin.
- Assessment of platelet aggregation induced by collagen and thrombin receptor agonist peptide.
- Analysis of platelet morphology, ultrastructure, and ATP release.
- Evaluation of surface and total alpha(IIb)beta(3) levels.
- Examination of tyrosine phosphoprotein levels following stimulation.
Main Results:
- Cholesterol depletion significantly decreased collagen and thrombin receptor agonist peptide-induced platelet aggregation.
- Aggregation induced by anti-CD9 or anti-beta(3) antibodies was unaffected by cholesterol depletion.
- Cholesterol depletion impaired microtubule ring formation, aggregate size, and the open canalicular system.
- Reduced ATP release and altered tyrosine phosphoprotein levels were observed in cholesterol-depleted platelets.
- Surface and total alpha(IIb)beta(3) levels remained equivalent between normal and depleted platelets.
Conclusions:
- Cholesterol depletion directly impairs human platelet aggregation, primarily by affecting platelet ultrastructure and secretion.
- The findings suggest cholesterol is critical for maintaining platelet structural integrity and signaling pathways involved in aggregation and secretion.
- These results highlight a potential mechanism linking cholesterol levels to thrombotic risk.
Abstract:
We investigated the direct role of cholesterol lowering on human platelet aggregation by in vitro cholesterol depletion using methyl-beta-cyclodextrin. Collagen and thrombin receptor agonist peptide induced maximal aggregation was significantly decreased in cholesterol depleted platelets. In contrast, anti-CD9 antibody, mAb7, or anti-beta(3) antibody, D3, induced percent maximal aggregation was unaffected by cholesterol depletion. Surface and total alpha(IIb)beta(3) levels were equivalent in both groups. Morphological and ultrastructural analysis of collagen induced aggregates revealed that normal and cholesterol depleted platelets changed shape and aggregated; however, cholesterol depletion impaired microtubule ring formation and aggregate size. Cholesterol depletion also diminished the extent of the open canalicular system and collagen induced platelet ATP release. These data suggest cholesterol depletion impairs platelet aggregation by altering platelet ultrastructure critical in mediating secretion. Temporal differences and differences in tyrosine phosphoprotein levels following collagen stimulation were observed, thereby indicating that platelet signaling was concurrently affected by cholesterol depletion.